CXCL1 has been found to positively correlate with colon cancer progression [40], and poor prognosis in breast cancer [41]; PAI-1 also plays an important role in tumor progression, invasion, and metastasis in breast cancer [42,43]. Here, SERPINE1 is linked to breast cancer.